Cite
Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection.
MLA
Yoshida, Hideo, et al. “Lamivudine Monoprophylaxis for Liver Transplant Recipients with Non-Replicating Hepatitis B Virus Infection.” Clinical Transplantation, vol. 21, no. 2, Mar. 2007, pp. 166–71. EBSCOhost, https://doi.org/10.1111/j.1399-0012.2006.00557.x.
APA
Yoshida, H., Kato, T., Levi, D. M., Regev, A., Madariaga, J. R., Nishida, S., Martinez, E. J., Schiff, E. R., Omata, M., & Tzakis, A. G. (2007). Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection. Clinical Transplantation, 21(2), 166–171. https://doi.org/10.1111/j.1399-0012.2006.00557.x
Chicago
Yoshida, Hideo, Tomoaki Kato, David M Levi, Arie Regev, Juan R Madariaga, Seigo Nishida, Enrique J Martinez, Eugene R Schiff, Masao Omata, and Andreas G Tzakis. 2007. “Lamivudine Monoprophylaxis for Liver Transplant Recipients with Non-Replicating Hepatitis B Virus Infection.” Clinical Transplantation 21 (2): 166–71. doi:10.1111/j.1399-0012.2006.00557.x.